What happens when the tools used to fight one of the deadliest cancers fail to tell the full story, and how can a new approach change the game? Glioblastoma, an aggressive brain cancer with a survival rate of less than 15 months for most patients, has long evaded effective treatment, but a
Imagine a world where life-saving medical research grinds to a halt, not because of a lack of expertise or innovation, but due to political disputes far removed from the lab. This scenario is unfolding across the University of California (UC) system, where federal funding freezes initiated by the
Imagine a world where a cancer diagnosis doesn't come with the added burden of financial ruin, where access to life-saving treatment depends not on income or zip code but on need alone, and where policies like Medicaid expansion bring this vision closer to reality. This cornerstone of healthcare
As we delve into the complex world of cancer biology, I’m thrilled to speak with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development. Ivan’s deep knowledge of technology and innovation in the industry offers unique insights into groundbreaking studies,
In the realm of clinical research, the conclusion of a trial often feels like crossing a finish line, with key milestones such as database lock, the final monitoring visit, or the last patient out signaling closure for sponsors and contract research organizations (CROs). However, for the
What if the key to defeating some of humanity's most devastating diseases lies within the tiniest boundaries of human cells, invisible to the naked eye, and only accessible through advanced technology? Membrane proteins, the unsung heroes of cellular function, act as gatekeepers, controlling the
